Ovid Therapeutics Inc
F:1OT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Ovid Therapeutics Inc
F:1OT
|
US |
|
ACQ Bure AB
F:0FE
|
SE |
|
C
|
Caleres Inc
F:BRP
|
US |
|
A
|
Amper SA
XMUN:APR
|
ES |
|
B
|
BAWAG Group AG
F:0B2
|
AT |
|
B
|
BOC Hong Kong Holdings Ltd
F:BOF
|
HK |
|
N
|
Netbay PCL
SET:NETBAY
|
TH |
|
Agora Inc
NASDAQ:API
|
CN |
|
Xtant Medical Holdings Inc
F:XMS
|
US |
|
F
|
Fuchs Se
DUS:FPE
|
DE |
|
C
|
Cantargia AB
F:7V3
|
SE |
|
E
|
Emergent BioSolutions Inc
F:ER4
|
US |
|
Mission Produce Inc
F:5YM
|
US |
|
M
|
Micro Leasing PCL
SET:MICRO
|
TH |
|
B
|
Beowulf Mining PLC
SWB:B4E
|
UK |
|
Toyo Tanso Co Ltd
OTC:TYOTF
|
JP |
|
B
|
Banca Sistema SpA
SWB:B2S
|
IT |
Shareholder Yield
Current shareholder yield for 
1OT is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
1OT Price
Ovid Therapeutics Inc
| Average Annual Return | -12.54% |
| Standard Deviation of Annual Returns | 59.23% |
| Max Drawdown | -95% |
| Market Capitalization | 474.1m EUR |
| Shares Outstanding | 70 810 661 |
| Percentage of Shares Shorted |
N/A
|
